Professor of Clinical Medicine
University of Cincinnati
Disclosure: Amgen (Grant/Research Support, outside the submitted work)Clinical Care Options (Other Financial or Material Support, outside the submitted work)Cytodyn (Grant/Research Support, outside the submitted work)Gilead Sciences (Grant/Research Support, outside the submitted work)Janssen (Grant/Research Support, outside the submitted work)Merck (Grant/Research Support, outside the submitted work)ViiV Healthcare (Research Grant or Support, outside the submitted work)
Dr. Fichtenbaum is a Professor of Clinical Medicine and Associate Chairman for Translational Research, Department of Internal Medicine. He graduated from the University of Missouri-Kansas City Combined BA/MD Program and completed an Internal Medicine-Pediatrics Residency at Bridgeport Hospital-Yale University. He completed post-doctoral training in AIDS and Infectious Diseases at Yale and Washington University, respectively. He was on faculty at Washington University from 1994-1999. In 1999, he joined the faculty at the University of Cincinnati. He is the Principal Investigator of the AIDS Clinical Trials Unit where he has an active clinical research program focused on HIV infection and inflammation. He has been a member of the AIDS Clinical Trials Group since 1993 and an active investigator in multi-center clinical trials. He currently serves as Vice-Chair of the REPRIEVE trial of pitavastatin versus placebo to reduce major cardiovascular adverse events in persons with HIV infection. He has authored more than 150 peer-reviewed scientific publications and book chapters. He is actively involved in the mentoring of students, residents, fellows and faculty.
